
Webinar: A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy – 12.07.2023
AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. In this webinar, hosted by DDW and supported by Azenta Life Sciences, we’ll help you understand the AAV workflow, from upstream methods for AAV production and… Read More












